P38 mapk endogenous inhibition improves neurological deficits in global cerebral ischemia/reperfusion mice

HIGHLIGHTS

• who: Kun Hou and collaborators from the Department of Cardiology, Yan`an Affiliated Hospital of Kunming Medical University, Kunming, China have published the research: p38 MAPK Endogenous Inhibition Improves Neurological Deficits in Global Cerebral Ischemia/Reperfusion Mice, in the Journal: Neural Plasticity 1d 3d of 29/06/2022
• what: In this study, all efforts were made to reduce the total number of animals used and minimize experimental animal suffering by following this principle. The authors demonstrate for the first time that the p38 MAPK pathway is involved in brain IRI based on p38 MAPK endogenous . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.